1. Dawson WR. The Egyptian medical papyri. In: Brothwell DR，Sandison AT（eds）. Diseases in Antiquity. Charles C. Thomas Publ，London，1967: 98-111.

2. Guo T，Adang AE，Dolle RE，et al. Small molecule biaryl FSH receptor agonists. Part 2. Lead optimization via parallel synthesis. Bioorg Med Chem Lett，2004，14: 1717-1720.

3. Vesalius A. De humani corporis fabrica libri septem. Basileae ［Basel］: Ex officina Joannis，Oporini，1543.

4. Fallopius G. Observationes.anatomicae. Venise，1561.

5. De Graaf R. De Mulierum Organis. Paris，1672.

6. von Leeuwenhoek A. Epistolae Physiologicae，1719.

7. Arey BJ，Deecher DC，Shen ES，et al.Identification and characterization of a selective，nonpeptide folliclestimulating hormone receptor antagonist. Endocrinology，2002，143: 3822-3829..

8. Hertwig O. Das Werden der Organismen: zur Widerlegung von Darwin's Zufallstheorie durch das Gesetz in der Entwicklung. G. Fischer，Jena，1916.

9. Berthold A. Transplantation der Hoden. Arch Anat Physiol Wissensch，1849; 4.

10. Bernard C. An Introduction to the Study of Experimental Medicine，1865.

11. Starling EH. The Croonian lecture on the chemical correlation of the function of the body. Lancet，1905，83: 339-342.

12. Crowe SJ，Cushing H，Homans J. Experimental hypophysectomy. Bull Johns Hopkins Hosp，1910，21: 127-167.

13. Ludwig M，Felberbaum RE，Diedrich K，et al. Ovarian Stimulation: From Basic Science to Clinical Application. Reprod Biomed Online，2002，5（Suppl 1）: 73-86.

14. Lunenfeld B. Historical Perspectives in Gonadotropin Therapy. Hum Reprod Update，2004，10: 453-467.

15. Zondek B. Weitere Untersuchungen zur Darstellung，Biologie und Klinik des Hypophysenvorderlappenhormones （Prolan）. Zentralblatt fur Gynaekologie，1929，14: 834-848.

16. Heller CG，Paulson CA，Mortimore GE，et al. Urinary gonadotrophins，spermatogenic activity，and classification of testicular morphology—their bearing on the utilization hypothesis. Ann N Y Acad Sci U.S.A，1952，55: 685-702.

17. Ryan KJ，Petro Z. Steroid biosynthesis by human ovarian granulosa and thecalcells. J Clin Endocrinol Metab，1966，26: 46-52.

18. Yalow Rs，Berson Sa. Immunoassay of endogenous plasma insulin in man. J Clin Invest，1960，39: 1157-1175.

19. Lunenfeld B，Eshkol A，et al. Immunology of human chorionic gonadotropin in Vitamins and Hormones. Academic Press，New York，1967; 137-190.

20. Naftolin F，Dillard Jr EA，Paulsen CA. Serum HLH levels in ovarian and systemic vein blood by radioimmunoassay. In: Rosenberg E（ed）.Gonadotropins. Geron-X，Los Altos，1968，373-379.

21. Salesse R，Remy JJ，Levin JM，et al. Towards understanding the glycoprotein hormone receptors. Biochimie，1991，73: 109-120.

22. Mazer C. Diagnosis and Treatment of Menstrual Disorders and Sterility. Am J Obstet Gynecol，1941，46: 474-588.

23. Yanofsky SD，Shen ES，Holden F，et al. Allosteric activation of the follicle-stimulating hormone（FSH）receptor by selective，nonpeptide agonists. J Biol Chem 2006; 281: 13226-13233.

24. Albert A. The kaolin-acetone method for processing urine for the routine clinical assay of human pituitary gonadotrophin. Acta Endocrinol（Copenh），1966，52（Suppl 106）: 5-64.

25. Borth R，Lunenfeld V，de Watteville H. Active gonadotrope d'un extrait d'urines de femmes en menopause. Experientia，1954，10: 266-268.

26. Borth R，Lunenfeld B，Riotton G，et al. Activite gonadotrope d'un extrait d'urines de femmes en menopause （2me communication）. Experientia，1957，13: 115.

27. Stabler S. A Criticism of the Present-day Management of the Barren Woman. Ulster Med J，1954，3: 14-22.

28. van de Lagemaat R，Timmers CM，Kelder J，et al. Induction of ovulation by a potent，orally active，low molecular weight agonist（Org 43553）of the luteinizing hormone receptor. Hum Reprod，2009，24: 640-648.

29. Borth R，Lunenfeld B，Menzi A. Pharmacologic and clinical effects of a gonadotropin preparation from post menopausal urine. In: Albert A（ed）. Human Gonadotropins，Charles C. Thomas Publ. Springfield，1961.

30. Lunenfeld B，Menzi A，Volet B. Clinical effects of human post-menopausal gonadotrophin. In: Fuchs F（ed）. Adivance abstracts of short communications. First International Congress of Endocrinology，Copenhagen，1960; 587.

31. Lunenfeld B，Rabau E，Rumney G，et al. The responsiveness of the human ovary to gonadotropin. （HypophysisⅢ）. Proc of Third World Cong Gynecol Obstet（Vienna）1961，1: 22.

32. Lunenfeld B，Sulimovici S，Rabau E，et al.L'induction de l'ovulation dans les amenorrheas hypophysaires par un traitement combinéde gonadotropines urinaires menopausiques et de gonadotropines chorioniques. CR Soc Franc Gynecol，1962，32/5: 346.

33. Lunenfeld B，Donini P. Le traitement de l'anovulation par les hormones gonadotropes humaines. Annales d'Endocrinologie，1964，25: 156.

34. Palmer R，Dorangeon P. Les gonadotropines dans les traitements de la stérilitéféminine. CR Soc Franc Gynecol，1962，32: 407-415.

35. Salomon Y，Netter A. Traitement de l'anovulation par les gonadotrophines humaines.Gazette Medicale de France，1965，72: 3615-3628.

36. Rosenberg E，Coleman J，Damani M，et al. Clinical effect of post Menopausal gonadotropin. Clin Endocrinol Metab，1962，23: 181-189.

37. Jones GS，De Moraes-Ruehsen M. Induction of ovulation with human gonadotropins and with clomiphene. Fertil Steril，1965，16: 461-484.

38. Taymor ML，Sturgis SH，Lieberman BL，Goldstein DP. Induction of ovulation with human postmenopausal gonadotropin. I. Case selection and results of therapy. Fertil Steril，1966，17: 731-735.

39. Gemzell C，Kjessler B. Treatment of infertility after partial hypophysectomy With human pituitary gonadotrophins. Lancet，1964，1: 644.

40. Apostolakis M，Bettendorf G，Voigt Kd. Clinico-experimental studies on human pituitary gonadotropin. Acta Endocrinol（Copenh），1962，41: 14-30.

41. Mozes M，Bogokowsky H，Antebi E，et al. Thromboembolic phenomena after ovarian stimulation with human gonadotropins. Lancet，1965，2: 1213.

42. Lunenfeld B. Complications following ovarian stimulation. Harefuah，1968，74: 382.

43. WHO Expert Committee on biological Standardization（Chair B. Lunenfeld）.Technical Report Series. Geneva，World Health Organization，1972，565: 56-57.

44. 98. Maclean D，Holden F，Davis AM，et al. Agonists of the follicle stimulating hormone receptor from an encoded thiazolidinone library. J Comb Chem，2004，6; 196-206.

45. WHO Expert Committee. Agents stimulating gonadal function in human（Chair B. Lunenfeld）. Technical Report Series. Geneva，World: Health Organization，1973; 514.

46. Lunenfeld B，Insler V. Classification of amenorrheic states and their treatment by ovulation induction. Clinical Endocrinology，1974，3: 223.

47. Lunenfeld B，Givol D，Sela M. Immunologic properties of urinary preparations of human menopausal gonadotropins，with special reference to Pergonal. J. Clin Endocrinol Metab，1961，21: 478.

48. Eshkol A，Lunenfeld B. Purification and separation of follicle stimulating hormone（FSH）and luteinizing hormone（LH）from human menopausal gonadotropin（HMG）. PartⅢ. Acta Endocrinol，1967，54: 919.

49. Lunenfeld B，Eshkol A. Immunology of follicle stimulating hormone and luteinizing hormone. Vitam Horm，1970，27: 131-159.

50. Yalow R，Berson S. Assay of plasma insulin in human subjects by immunological methods. Nature，1959，184（Suppl 21）: 1648-1649.

51. Hackel.er BJ. Ultrasonic demonstration of follicular development. Lancet，1978，1: 941.

52. Dumble LD，Klein RD. Creutzfeld-Jakob disease legacy for Australian women treated with human pituitary gonadotropins. Lancet，1992，330: 848.

53. Cochius JI，Mack K，Burns RJ. Creutzfeld-Jakob disease in a recipient human pituitary derived gonadotropin. Aust NZ J Med，1990，20: 592.

54. Greenblatt R，Barfield W，Jungck E，et al. Induction of ovulation with MRL/41. Preliminary report. JAMA，1961，178: 101-104.

55. Greenblatt RB，Faucher G，Mahesh VB，et al. Ovulation and pregnancy in the Chiari-Frommel syndrome. Report of 10 cases. Fertil Steril，1966，17: 742-756.

56. Shelesnyak M，Lunenfeld B，Honig B. Studies on the mechanism of ergocornine interference with decidualization and nidation IⅡurinary steroids after administration of ergocornine to women. Life Sci，1963，1: 73-79.

57. Lindner HR，Lunenfeld B，Shelesnyak MC. Plasma levels of progesterone and cortisol，and urinary pregnanediol excretion during the post-ovulatory phase of the cycle in normal and ergocornine-treated women. Acta Endocrinologica，1967，56: 35.

58. Varga L，Wenner R，Del Pozo E. Treatment of galactorrheaamenorrhea syndrome with Br-ergocryptine（CB 154）: restoration of ovulatory function and fertility. Am J Obstet Gynecol，1973，117: 75-79.

59. Guillemin R，Jutisz M，Sakiz E.，The partial purification of an hypothalamic factor（LRF）stimulating the secretion of pituitary luteinizing hormone（LH）. C R Hebd Seances Acad Sci，1963，256: 504-507.

60. Schiavi R，Jutisz M，Sakiz E，et al. Stimulation of ovulation by purified LH-releasing factor（lrf）in animals rendered anovulatory by hypothalamic lesion. Proc Soc Exp Biol Med，1963，114: 426-429.

61. Monahan M，Rivier J，Burgus R，et al. Total synthesis by solid phase of a decapeptide stimulating the secretion of LH and FSH pituitary gonadotropins. C R Acad Sci Hebd Seances Acad Sci D，1971; 273: 508-510.

62. Schally AV，Arimura A，Kastin AJ，et al. Gonadotropinreleasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science，1971，173: 1036-1038.

63. Potashnik G，Homburg R，Eshkol A，et al. Clinical application of intranasal self-administered gonadotrophin releasing hormone. Isr J Med Sci，1975，11: 518.

64. Knobil E，Plant TM，Wildt L，et al. Control of the rhesus monkey menstrual cycle: permissive role of hypothalamic gonadotropin-releasing hormone. Science，1980，21; 207: 1371-1373.

65. Leyendecker G，Wildt L，Hansmann M. Pregnancies following chronic intermittent（pulsatile）administration of GnRH by means of a portable pump（Zyklomat）-a new approach to the treatment of infertility in hypothalamic amenorrhea. J Clin Endocrinol Metab，1980，51: 1214-1216.

66. Shirodkar VN. Surgical treatment of female sterility. J Indian Med Assoc，1957，29: 56-57.

67. Buxton CL，MastroianniⅠJr. Surgical treatment of infertility. Obstet Gynecol，1962，20: 844-851.

68. Gomel V. Laparoscopic tubal surgery in infertility. Obstet Gynecol，1975，46: 47-48.

69. Biggers JD. Walter Heape，FRS: a pioneer in reproductive biology. J Reprod Fert，1991，173: 186.

70. Pincus G，Enzmann EV. Can Mammalian Eggs Undergo Normal Development in Vitro？Proc Natl Acad Sci U S A，1934，20: 121-122.

71. Rock J，Menkin MF. In vitro fertilization and cleavage of human ovarian eggs. Science，1944，100: 105-107.

72. Chang Mc. Fertilization of rabbit ova in vitro. Nature，1959，184（Suppl 7）: 466-467.

73. Trounson AO，Leeton JF，Wood C，et al. Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science，1981，212: 681-682.

74. Steptoe PC，Edwards RG. Birth after the reimplantation of a human embryo. Lancet，1978，2: 366.

75. Jones GS，Andrews MC，Acosta A，et al. The program for in vitro fertilization at Norfolk. Fertil Steril，1982，38: 14-21.

76. Fleming R，Jamieson ME，Hamilton MP，et al. The use of GnRH analogues in combination with exogenous gonadotropins in infertile women. Acta Endocrinol Suppl（Copenh），1988，288: 77-84.

77. Temple-Smith PD，Southwick GJ，Yates CA，et al. Human pregnancy by in vitro fertilization（IVF）using sperm aspirated from the epididymis. J In Vitro Fert Embryo Transf，1985，2: 119-122.

78. Patrizio P，Silber S，Ord T，et al. Two births after microsurgical sperm aspiration in congenital absence of vas deferens. Lancet，1988，2: 1364.

79. Ng SC，Bongso A，Ratnam SS，et al. Pregnancy after transfer of sperm under zona. Lancet，1988，2: 790.

80. Palermo G，Joris H，Devroey P，et al. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet，1992，340: 17-18.

81. Schoysman R，Vanderzwalmen P，Nijs M，et al. Pregnancy after fertilisation with human testicular spermatozoa. Lancet，1993，342: 1237.

82. Silber SJ，Van Steirteghem AC，Liu J，et al. High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicle biopsy. Hum Reprod，1995，10: 148-152.

83. Palermo G，Joris H，Devroey P，et al. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet，1992，340: 17-18.

84. Agrawal R，West C，Conway GS，et al. Pregnancy after treatment with three recombinant gonadotropins. Lancet，1997，349: 29-30.

85. Donderwinkel P，Schoot D，Coelingh I，et al. Pregnancy after induction of ovulation with recombinant human FSH in polycystic ovary syndrome. Lancet，2002，340: 983.

86. Hugues JN，Barlow DH，Rosenwaks Z，et al. Improvement in consistency of response to ovarian stimulation with recombinant human follicle stimulating hormone resulting from a new method for calibrating the therapeutic preparation. Reprod Biomed Online，2003，6: 185-190.

87. Bosch E. Recombinant human follicular stimulating hormone and recombinant human luteinizing hormone in a 2; 1 ratio combination. Pharmacologicalcharacteristics and clinical applications. Expert Opin Biol Ther，2010，10: 1001-1009.

88. Bühler KF，Fischer R. Recombinant human LH supplementation versus supplementation with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH agonist protocol: a matched casecontrol study. Gynecol Endocrinol，2012，28: 345-350.

89. Paterson ND，Foong SC，Greene CA. Improved pregnancy rates with luteinizing hormone supplementation in patients undergoing ovarian stimulation for IVF. J Assist Reprod Genet，2012.

90. Beckers N，Macklon N，Devroey P，et al. First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone（FSH）agonist（recFSH-CTP）for in vitro fertilization. Fertil Steril，2003，79: 621-623.

91. The Corifollitropin Alfa Dose-finding Study Group. A randomized dose-response 482 trial of a single injection of corifollitropin alfa to sustain multifollicular growth 483 during controlled ovarian stimulation. Hum Reprod，2008，23: 2484-2492.

92. de Greef R，Zandivliet AS，de Haan AF，et al.Dose selection of corifollitropin alfa by modeling and simulation in controlled ovarian stimulation. Clin Pharmacol Ther，2010，88: 79-87.

93. Devroey P，Boostanfar R，Koper N，et al. ENGAGE investigators. A double-blind，non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod，2009，24: 3063-3072.

94. Mannaerts B. The corifollitropin alpha ENSURE study group. Corifollitropin alfa for ovarian stimulation in IVF: a randomized trial in lower-body-weight women. Reprod BioMed Online 2010; 21: 66-76.

95. Fatemi HM，OberyéJ，Popovic-Todorovic B，et al.Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial. Fertil Steril，2010，94: 1922-1924.